Annual Total Expenses
$22.06 M
-$9.71 M-30.57%
31 December 2023
Summary:
Cardiol Therapeutics annual total expenses is currently $22.06 million, with the most recent change of -$9.71 million (-30.57%) on 31 December 2023. During the last 3 years, it has risen by +$6.62 million (+42.85%). CRDL annual total expenses is now -30.57% below its all-time high of $31.77 million, reached on 31 December 2022.CRDL Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$10.36 M
+$4.71 M+83.20%
30 September 2024
Summary:
Cardiol Therapeutics quarterly total expenses is currently $10.36 million, with the most recent change of +$4.71 million (+83.20%) on 30 September 2024. Over the past year, it has increased by +$4.66 million (+81.64%). CRDL quarterly total expenses is now -0.28% below its all-time high of $10.39 million, reached on 01 December 2021.CRDL Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.6% | +81.6% |
| 3 y3 years | +42.9% | +28.4% |
| 5 y5 years | +281.5% | +281.9% |
CRDL Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -30.6% | +42.9% | -0.3% | +120.7% |
| 5 y | 5 years | -30.6% | +281.5% | -0.3% | +351.5% |
| alltime | all time | -30.6% | +1692.0% | -0.3% | +2459.8% |
Cardiol Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.36 M(+83.2%) |
| June 2024 | - | $5.66 M(-9.2%) |
| Mar 2024 | - | $6.23 M(+5.7%) |
| Dec 2023 | $22.06 M(-30.6%) | $5.90 M(+3.4%) |
| Sept 2023 | - | $5.70 M(+21.5%) |
| June 2023 | - | $4.69 M(-18.4%) |
| Mar 2023 | - | $5.75 M(-14.1%) |
| Dec 2022 | $31.77 M(+2.8%) | $6.70 M(-33.9%) |
| Sept 2022 | - | $10.12 M(+40.1%) |
| June 2022 | - | $7.22 M(-6.5%) |
| Mar 2022 | - | $7.72 M(-25.7%) |
| Dec 2021 | $30.90 M | - |
| Dec 2021 | - | $10.39 M(+28.8%) |
| Sept 2021 | - | $8.07 M(+52.4%) |
| June 2021 | - | $5.29 M(-25.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $7.09 M(-4.0%) |
| Dec 2020 | $15.44 M(+45.1%) | $7.38 M(+123.0%) |
| Sept 2020 | - | $3.31 M(+28.0%) |
| June 2020 | - | $2.59 M(+12.7%) |
| Mar 2020 | - | $2.29 M(-8.0%) |
| Dec 2019 | $10.64 M(+84.1%) | $2.49 M(-8.1%) |
| Sept 2019 | - | $2.71 M(-3.3%) |
| June 2019 | - | $2.80 M(+6.6%) |
| Mar 2019 | - | $2.63 M(+6.3%) |
| Dec 2018 | $5.78 M(+369.7%) | $2.48 M(+32.9%) |
| Sept 2018 | - | $1.86 M(+92.4%) |
| June 2018 | - | $968.30 K(+128.7%) |
| Mar 2018 | - | $423.40 K(-5.7%) |
| Dec 2017 | $1.23 M | $449.10 K(+10.9%) |
| Sept 2017 | - | $404.80 K |
FAQ
- What is Cardiol Therapeutics annual total expenses?
- What is the all time high annual total expenses for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual total expenses year-on-year change?
- What is Cardiol Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly total expenses year-on-year change?
What is Cardiol Therapeutics annual total expenses?
The current annual total expenses of CRDL is $22.06 M
What is the all time high annual total expenses for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual total expenses is $31.77 M
What is Cardiol Therapeutics annual total expenses year-on-year change?
Over the past year, CRDL annual total expenses has changed by -$9.71 M (-30.57%)
What is Cardiol Therapeutics quarterly total expenses?
The current quarterly total expenses of CRDL is $10.36 M
What is the all time high quarterly total expenses for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly total expenses is $10.39 M
What is Cardiol Therapeutics quarterly total expenses year-on-year change?
Over the past year, CRDL quarterly total expenses has changed by +$4.66 M (+81.64%)